chr20-33677440-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005225.3(E2F1):c.826G>A(p.Val276Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00094 in 1,614,044 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005225.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
E2F1 | NM_005225.3 | c.826G>A | p.Val276Met | missense_variant | 5/7 | ENST00000343380.6 | NP_005216.1 | |
E2F1 | XM_047439961.1 | c.*68G>A | 3_prime_UTR_variant | 5/5 | XP_047295917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
E2F1 | ENST00000343380.6 | c.826G>A | p.Val276Met | missense_variant | 5/7 | 1 | NM_005225.3 | ENSP00000345571 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00479 AC: 729AN: 152166Hom.: 8 Cov.: 32
GnomAD3 exomes AF: 0.00117 AC: 293AN: 251294Hom.: 3 AF XY: 0.000854 AC XY: 116AN XY: 135808
GnomAD4 exome AF: 0.000540 AC: 789AN: 1461760Hom.: 8 Cov.: 33 AF XY: 0.000455 AC XY: 331AN XY: 727200
GnomAD4 genome AF: 0.00478 AC: 728AN: 152284Hom.: 8 Cov.: 32 AF XY: 0.00462 AC XY: 344AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 18, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
E2F1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at